DE2600069A1 - Pharmazeutische praeparate - Google Patents

Pharmazeutische praeparate

Info

Publication number
DE2600069A1
DE2600069A1 DE19762600069 DE2600069A DE2600069A1 DE 2600069 A1 DE2600069 A1 DE 2600069A1 DE 19762600069 DE19762600069 DE 19762600069 DE 2600069 A DE2600069 A DE 2600069A DE 2600069 A1 DE2600069 A1 DE 2600069A1
Authority
DE
Germany
Prior art keywords
pharmaceutically acceptable
propanol
isopropylamino
phenyloxy
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762600069
Other languages
German (de)
English (en)
Inventor
Peter Rolf Dr Imhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE2600069A1 publication Critical patent/DE2600069A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19762600069 1975-01-06 1976-01-02 Pharmazeutische praeparate Withdrawn DE2600069A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06

Publications (1)

Publication Number Publication Date
DE2600069A1 true DE2600069A1 (de) 1976-07-15

Family

ID=4178628

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762600069 Withdrawn DE2600069A1 (de) 1975-01-06 1976-01-02 Pharmazeutische praeparate

Country Status (14)

Country Link
JP (1) JPS5191337A (cs)
AU (1) AU499140B2 (cs)
BE (1) BE837293A (cs)
CA (1) CA1063516A (cs)
DE (1) DE2600069A1 (cs)
FR (1) FR2296430A1 (cs)
GB (1) GB1510370A (cs)
HK (1) HK49680A (cs)
IE (1) IE42766B1 (cs)
IL (1) IL48785A (cs)
MY (1) MY8100159A (cs)
NL (1) NL7600045A (cs)
NZ (1) NZ179623A (cs)
ZA (2) ZA7628B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782852A1 (en) * 1991-11-20 1997-07-09 Takeda Chemical Industries, Ltd. Pharmaceutical compositions of heterocyclic angiotensin-II antagonists for oral use and method of preparing them

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37700A (en) * 1970-10-02 1975-05-22 Ciba Geigy Ag Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782852A1 (en) * 1991-11-20 1997-07-09 Takeda Chemical Industries, Ltd. Pharmaceutical compositions of heterocyclic angiotensin-II antagonists for oral use and method of preparing them

Also Published As

Publication number Publication date
HK49680A (en) 1980-09-12
IE42766L (en) 1976-07-06
ZA7626B (en) 1976-12-29
JPS5191337A (cs) 1976-08-10
IL48785A0 (en) 1976-03-31
IL48785A (en) 1978-08-31
NL7600045A (nl) 1976-07-08
AU499140B2 (en) 1979-04-05
CA1063516A (en) 1979-10-02
ZA7628B (en) 1976-12-29
AU1000276A (en) 1977-07-14
IE42766B1 (en) 1980-10-08
MY8100159A (en) 1981-12-31
BE837293A (fr) 1976-07-05
GB1510370A (en) 1978-05-10
FR2296430B1 (cs) 1978-11-10
FR2296430A1 (fr) 1976-07-30
NZ179623A (en) 1978-03-06

Similar Documents

Publication Publication Date Title
EP0771197B1 (de) Verwendung heterocyclischer verbindungen als dopamin-d 3 liganden
DE60317466T2 (de) Nicotinamidderivate, die als PDE4--Inhibitoren einsetzbar sind
DE3037770C2 (de) N-Niedrigalkyl-3-phenoxy-1-azetidincarboxamide und diese Verbindungen enthaltende Zubereitungen
JPH0825879B2 (ja) 抗うつまたは抗パーキンソン病薬
EP0038438B1 (de) Substituierte 1,2,5-Oxadiazol-2-oxide zur Anwendung als Arzneimittel und sie enthaltende Arzneimittel
DE3855520T2 (de) Methode zur Verbesserung des Schlafes
DE2502993A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0306846A2 (de) Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
JPS5965047A (ja) ２―ニトロ―１、１―エテンジアミン類およびそれらの製造法
US5866574A (en) Pancreatitis remedy
DE2600069A1 (de) Pharmazeutische praeparate
DE69426620T2 (de) Antidepressiva
DE102004021779A1 (de) Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1137438B1 (de) Zubereitung mit verbesserter therapeutischer breite, enthaltend nukleotidsyntheseinhibitoren
EP0262395A2 (de) Sulfonamido-äthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE69909592T4 (de) Verwendung von thiadiazolo[4,3-a]pyridine derivaten
EP0508955B1 (de) Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe
US3210247A (en) Anti-epileptic i-cyclohexyl-z-methyl- aiviino propane salt of phenyl ethyl barbituric acid
US4161530A (en) Pharmaceutical combination preparations as hypnotics
EP0314984A2 (de) Verwendung von 2-Pyrimidinyl-1-piperazin-Derivaten
DE1770135A1 (de) Verfahren zur Herstellung von 2,4-Benzdiazepinen
DE2600070A1 (de) Pharmazeutische kombinationspraeparate
DE4111026A1 (de) Optisch aktive carbonsaeuren sowie diese enthaltende arzneimittel
CH672069A5 (cs)
EP0019586A1 (de) Neue antithrombotische Kombinationspräparate

Legal Events

Date Code Title Description
8130 Withdrawal